UCLB’s spinout creation achievements awarded at One Nucleus

We are delighted to announce that UCLB won the Best Performing New Company Creator of the Year award at last night’s One Nucleus Annual Awards. 

Members of UCLB’s Biopharm team joined life science innovators at last night’s event in London to celebrate their incredible achievements. The One Nucleus Award categories are structured to reflect the breadth of R&D, investment, service provision and enabling support across the stakeholders. 

UCLB won the Best Performing New Company Creator of the Year award, a category that assesses technology transfer offices, accelerators/incubators, start-up funders and advisers creating and supporting new ventures. 

The category assesses criteria including new company creation activity, internal investment, external investment secured, business support provided, support of founder diversity and promotion of entrepreneurship in life sciences. 

Mark Fisher, Associate Director of BioPharm, UCLB, said: “UCLB is honoured to be acknowledged for our role in supporting and advancing UCL’s dynamic spin-out ecosystem. The award reflects UCLB’s dedication to fostering innovation, translating groundbreaking research into impactful ventures, and driving positive change across industries and communities.  

“It also reflects the depth of experience provided by the whole team at UCLB and underlines the importance of direct access to venture-growing funds – such as our own Proof of Concept fund, and external venture capital – that accelerate company growth.” 

 

Discover more: 

One Nucleus Awards